Search

Your search keyword '"Vioxx (Medication) -- Cases"' showing total 232 results
Start Over Descriptor "Vioxx (Medication) -- Cases"
232 results on '"Vioxx (Medication) -- Cases"'

2. Merck and the Vioxx debacle: deadly loyalty.

Author

Culp, David R. and Berry, Isobel

Subjects
Vioxx (Medication) -- Cases, Class actions (Civil procedure) -- Laws, regulations and rules, Products liability -- Laws, regulations and rules, Patent law -- Evaluation, Government regulation, Company legal issue
Published
2007

3. The Vioxx litigation paradigm: the search for smoking guns.

Author

Champion, Walter T.

Subjects
Vioxx (Medication) -- Cases, Pharmaceutical industry -- Marketing, Consumer advertising -- Laws, regulations and rules, Company marketing practices, Government regulation, Company legal issue
Published
2006

4. The Vioxx pharmaceutical scandal: Peterson v. Merke Sharpe & Dohme.

Author

Faunce, Thomas A., Townsend, Ruth, and McEwan, Alexandra

Subjects
Vioxx (Medication) -- Cases, Clinical trials -- Laws, regulations and rules, Negligence -- Laws, regulations and rules, Products liability -- Laws, regulations and rules, Peterson v. Merke Sharpe & Dohme Pty. (184 F.C.R. 1 (Austl. Fed. Ct. 2010)), Company legal issue, Government regulation, Australia. Trade Practices Act 1974
Published
2010

5. After Vioxx: the national focus on the Merck & Co. trials is calling attention to product liability insurance and its future with large drug manufacturers

Author

Cavanaugh, Bonnie Brewer

Subjects
Merck & Company Inc. -- Cases -- Services -- Forecasts and trends, Aon Corp. -- Services -- Forecasts and trends -- Cases, Vioxx (Medication) -- Cases, Insurance industry -- Services -- Cases -- Forecasts and trends, Products liability insurance -- Forecasts and trends -- Cases -- Services, Pharmaceutical industry -- Cases -- Forecasts and trends -- Services, Business, Insurance, Company legal issue, Market trend/market analysis, Insurance industry, Cases, Services, Forecasts and trends
Abstract

In April, jurors in the latest Vioxx trial in Atlantic City, N.J., delivered a split decision. One plaintiff emerged victorious with a $13.5 million award, including $9 million in punitive [...]

Published
2006

6. Jury Riggers

Author

Crowley, Michael

Subjects
Vioxx (Medication) -- Cases, Analgesia -- Cases, Pharmaceutical industry -- Cases, Company legal issue, Merck & Company Inc. -- Cases
Published
2006

7. Litigation lessons from the Vioxx verdicts.

Author

Neufer, Nancy L., Berman, Scott L., and Duboff, Robert S.

Subjects
Vioxx (Medication) -- Cases, Pharmaceutical industry -- Laws, regulations and rules, Products liability -- Laws, regulations and rules, Personal injuries -- Laws, regulations and rules, Company legal issue, Government regulation
Published
2006

8. Vioxx, radiology, and the Food and Drug Administration

Author

Pentecost, Michael J.

Subjects
United States. Food and Drug Administration -- Standards, United States. Food and Drug Administration -- Evaluation, Drug approval -- Laws, regulations and rules, Ionizing radiation -- Complications and side effects, Radiology -- Practice, Radiology, Medical -- Practice, Company legal issue, Government regulation, Health, Vioxx (Medication) -- Cases
Published
2005

9. New Cox-2 pain relievers are marketing marvel, not miracle drugs.

Author

Porter, Rebecca

Subjects
Vioxx (Medication) -- Cases, Celebrex (Medication) -- Cases, Drugs -- Cases, Products liability -- Cases, Pharmaceutical industry -- Cases, Company legal issue
Abstract

Pharmacia Corp. (recently acquired by Pfizer, Inc.) makes what was the 10th most frequently prescribed drug in the United States last year. It touts Celebrex as "a major advance in [...]

Published
2002

10. Your dangerous drugstore

Author

Angell, Marcia

Subjects
Pharmaceutical industry -- Cases, Pharmaceutical industry -- Product defects and recalls, Pharmaceutical industry -- Public relations, Consumer protection -- Standards, Consumer protection -- Laws, regulations and rules, Drug approval -- Safety and security measures, Company legal issue, Company public relations, Government regulation, Literature/writing, Vioxx (Medication) -- Cases
Abstract

The article examines the court ruling regarding the role of the arthritis drug Vioxx in causing a debilitating heart attack in the plantiff, and the resultant impact on the public's opinion of and trust in pharmaceutical companies. Reforms are proposed for improving safety and health in drug development and dispensing.

Published
2006

11. Health plans' class-action Vioxx suit denied

Subjects
Class actions (Civil procedure) -- Laws, regulations and rules, Compromise and settlement -- Management, Government regulation, Company legal issue, Company business management, Health, Vioxx (Medication) -- Health aspects, Vioxx (Medication) -- Cases
Abstract

With the Vioxx settlement administrator ready to begin making interim payments to persons who submitted claims for myocardial infarctions or strokes related to using the analgesic, employer-sponsored health plans that [...]

Published
2008

12. The torch is dimming on tort cases

Subjects
Company legal issue, Business, regional, Law, Baycol (Medication) -- Political aspects, Baycol (Medication) -- Cases, Vioxx (Medication) -- Political aspects, Vioxx (Medication) -- Cases
Published
2007

13. In brief: Scorn in the USA

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Patients -- Cases, Company legal issue, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Vioxx (Medication) -- Cases
Abstract

British patients fighting a legal battle with drug manufacturer Merck over the withdrawn painkiller Vioxx have failed in their attempt to have their cases tried in the USA. A New [...]

Published
2006

14. Vioxx case coming to a head in New Orleans

Subjects
Merck & Company Inc. -- Cases, Heart attack -- Cases, Pharmaceutical industry -- Cases, Company legal issue, Business, Business, regional, Vioxx (Medication) -- Cases
Abstract

Byline: CityBusiness Staff Report Attorneys for a Kentucky man told a federal jury Tuesday that Merck & Co. should be held accountable for the heart attack he suffered after taking [...]

Published
2006

15. Vioxx Watch

Author

Maurer, Harry

Subjects
Company legal issue, Merck & Company Inc. -- Cases, Vioxx (Medication) -- Cases, Pharmaceutical industry -- Cases
Published
2006

16. Is Merck Winning or Losing in the Vioxx Trials?

Author

Simons, John

Subjects
Vioxx (Medication) -- Cases, Pharmaceutical industry -- Management, Pharmaceutical industry -- Cases, Company business management, Company legal issue, Merck & Company Inc. -- Management, Merck & Company Inc. -- Cases
Published
2006

17. Vioxx Pain Gets Worse

Subjects
Company legal issue, Merck & Company Inc. -- Cases, Merck & Company Inc. -- Remedies, Vioxx (Medication) -- Cases, Pharmaceutical industry -- Remedies, Pharmaceutical industry -- Cases
Published
2006

18. Juror Questions Were Allowed in Vioxx Trial

Author

Brennan, Lisa

Subjects
Merck & Company Inc. -- Cases, Analgesics -- Cases, Pharmaceutical industry, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Cases
Published
2006

19. Irregular Schedule Faces Latest Vioxx Trial

Author

Jeffreys, Brenda Sapino

Subjects
Merck & Company Inc. -- Cases, Breach of warranty -- Cases, Fraud -- Cases, Negligence -- Cases, Pharmaceutical industry -- Cases, Product safety -- Cases, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Cases
Published
2006

20. Attorneys in Texas Vioxx case struggle with trial schedule

Author

Jeffreys, Brenda Sapino

Subjects
COX-2 inhibitors -- Complications and side effects, COX-2 inhibitors -- Cases, District courts -- Cases, Personal injuries -- Cases, Company legal issue, Law, Carol A. Ernst, et al. v. Merck and Co. Inc., Vioxx (Medication) -- Cases, Vioxx (Medication) -- Complications and side effects
Published
2006

21. Intermittent Trial Schedule Faces Counsel in Valley Vioxx Suit

Author

Jeffreys, Brenda Sapino

Subjects
Merck & Company Inc. -- Cases, Negligence -- Cases, Pharmaceutical industry -- Cases, Products liability -- Cases, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Cases
Published
2006

22. Predictions for 2006

Author

Donald, Mark

Subjects
Attorneys -- Forecasts and trends, Attorneys -- Management, Market trend/market analysis, Company business management, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Cases
Published
2005

23. Merck's Latest Lumps

Subjects
Company legal issue, Merck & Company Inc. -- Cases, Merck & Company Inc. -- Product information, Vioxx (Medication) -- Complications and side effects, Vioxx (Medication) -- Cases, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Product information, Products liability -- Cases
Published
2005

24. PRESTO: A NEW VIOXX LIABILITY ESTIMATE! Why analysts' reports shift wildly with every twist in litigation against Merck

Author

Orey, Michael

Subjects
Lawsuit/litigation, Company legal issue, Market trend/market analysis, Merck & Company Inc. -- Cases, Arlington Asset Investment Corp. -- Officials and employees, Vioxx (Medication) -- Cases, Financial analysts -- Reports, Investment banks -- Officials and employees, Actions and defenses -- Economic aspects, Pharmaceutical industry -- Cases, Compromise and settlement -- Forecasts and trends
Published
2005

25. First Federal Vioxx Case to Serve as State Court Tiebreaker

Author

Jeffreys, Brenda Sapino

Subjects
Merck & Company Inc. -- Cases, Drugs -- Cases, Pharmaceutical industry -- Cases, Product safety -- Cases, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Cases
Published
2005

26. Pain Relief For Merck

Author

Maurer, Harry

Subjects
Lawsuit/litigation, Company legal issue, Company restructuring/company reorganization, Company organization, Merck & Company Inc. -- Cases, Merck & Company Inc. -- Reorganization and restructuring, Vioxx (Medication) -- Complications and side effects, Vioxx (Medication) -- Cases, Zocor (Medication) -- Intellectual property, Drugs -- Cases, Drugs -- Complications and side effects, Drugs -- Intellectual property, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Reorganization and restructuring, Actions and defenses
Published
2005

27. Merck Vioxx win fails to daunt Britons

Subjects
Merck & Company Inc. -- Product development, Merck & Company Inc. -- Cases, Pharmaceutical industry -- Product development, Pharmaceutical industry -- Cases, COX-2 inhibitors -- Product development, Company legal issue, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Vioxx (Medication) -- Cases, Vioxx (Medication) -- Complications and side effects
Abstract

Britons remain determined to challenge Merck in the US courts despite the pharmaceutical firm's victory in the second Vioxx trial, legal firms have said. A New Jersey court's ruling that [...]

Published
2005

29. Vioxx's N.J. defense team shows signs of splintering

Author

Brennan, Lisa

Subjects
Merck & Company Inc. -- Contracts, Merck & Company Inc. -- Cases, Williams and Connolly -- Officials and employees, Williams and Connolly -- Contracts, Analgesics -- Cases, Law firms -- Officials and employees, Law firms -- Contracts, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Contracts, Products liability -- Cases, Contract agreement, Company legal issue, Law, Vioxx (Medication) -- Cases
Published
2005

30. Drug Bust

Author

MacDonald, Elizabeth

Subjects
Zyprexa (Medication) -- Cases, Zyprexa (Medication) -- Complications and side effects, Zyprexa (Medication) -- Health aspects, Vioxx (Medication) -- Cases, Vioxx (Medication) -- Health aspects, Vioxx (Medication) -- Complications and side effects, Compromise and settlement -- Management, Sales -- Statistics, Pharmaceutical industry -- Cases, Antipsychotic drugs -- Complications and side effects, Antipsychotic drugs -- Health aspects, Antipsychotic drugs -- Cases, Analgesics -- Complications and side effects, Analgesics -- Health aspects, Analgesics -- Cases, Class actions (Civil procedure), Sales analysis, Company legal issue, Company business management, Merck & Company Inc. -- Cases, Eli Lilly and Co. -- Cases
Published
2005

31. Inadmissible

Subjects
Merck & Company Inc. -- Cases, National parks and reserves -- Discovery and exploration, Appellate courts -- Officials and employees, Liability (Law) -- Cases, Pharmaceutical industry -- Cases, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Complications and side effects, Vioxx (Medication) -- Cases
Published
2005

32. Deconstructing Vioxx

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Personal injuries -- Cases, Analgesics -- Cases, Analgesics -- Risk factors, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Risk factors, Vioxx (Medication) -- Cases
Published
2005

33. A Big Jury Verdict In the Vioxx Case

Subjects
Vioxx (Medication) -- Cases, Vioxx (Medication) -- Product defects and recalls, Verdicts -- Analysis, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Product defects and recalls, Men -- Death of, Limitation of damages -- Laws, regulations and rules, Heart attack -- Causes of, Heart attack -- Risk factors, Analgesics -- Cases, Analgesics -- Product defects and recalls, Damages, Texas -- Laws, regulations and rules, Company legal issue, Government regulation, Merck & Company Inc. -- Cases, Merck & Company Inc. -- Product defects and recalls
Published
2005

34. Vioxx ruling won't add to liability cover woes

Author

Bradford, Michael and Parekh, Rupal

Subjects
Merck & Company Inc. -- Cases -- Finance, Vioxx (Medication) -- Cases, Pharmaceutical industry -- Cases -- Finance, Business, Insurance, Company legal issue, Company financing, Finance, Cases
Abstract

Byline: MICHAEL BRADFORD and RUPAL PAREKH WHITEHOUSE STATION, N.J.-Pharmaceutical companies, long avoided by many insurers and charged high premiums by those who do remain in the market, should not expect [...]

Published
2005

35. Late News; Merck to appeal Vioxx award

Subjects
Merck & Company Inc. -- Cases -- Discipline -- Service introduction, WestPoint Stevens Inc. -- Discipline -- Cases -- Service introduction, Aetna Inc. -- Service introduction -- Cases -- Discipline, United States. Pension Benefit Guaranty Corp. -- Discipline -- Cases, Vioxx (Medication) -- Cases, Medication errors -- Cases, Insurance industry -- Service introduction -- Cases -- Discipline, Textile industry -- Discipline -- Cases -- Service introduction, Analgesics -- Cases, Pharmaceutical industry -- Cases -- Service introduction -- Discipline, Business, Insurance, Company legal issue, Insurance industry, Company service introduction, Service introduction, Cases, Discipline
Abstract

Merck & Co. Inc. plans to appeal a $253.4 million jury award to the widow of a man killed by the drugmaker's painkiller Vioxx. A Texas state court jury on [...]

Published
2005

36. Merck Says Vioxx Plaintiff Lied, Moves to Dismiss Case

Author

Coyle, Marcia

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Cases, Vioxx (Medication) -- Complications and side effects
Published
2005

37. On The Firing Line At Embattled Merck; With claims against Vioxx mounting, Ken Frazier is in for the fight of his career

Author

Barrett, Amy

Subjects
License lawsuit, Lawsuit/litigation, Company business planning, Company business management, Company legal issue, Merck & Company Inc. -- Officials and employees, Vioxx (Medication) -- Cases, Defense (Civil procedure) -- Management, Defense (Civil procedure) -- Planning, Products liability -- Cases, Actions and defenses -- Management, Corporate counsel -- Management, Pharmaceutical industry -- Officials and employees
Published
2004

38. Merck Looks to Big-Time Firms for Vioxx Cases

Author

Henning, Lily

Subjects
Merck & Company Inc. -- Product discontinuation, Merck & Company Inc. -- Cases, Merck & Company Inc. -- Management, Pharmaceutical industry -- Product discontinuation, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Management, Complex litigation -- Management, Company legal issue, Company business management, Business, regional, Law, Vioxx (Medication) -- Cases, Vioxx (Medication) -- Product discontinuation
Published
2004

39. Rofecoxib hearings point to failures in clinical testing design, decision-making transparency

Subjects
Merck & Company Inc. -- Cases, Vioxx (Medication) -- Cases, Rofecoxib -- Cases, Pharmaceutical industry -- Cases, Pharmaceuticals and cosmetics industries, Company legal issue, Cases
Abstract

In opening statements at a Senate committee on finance hearing on November 18 entitled 'FDA, Merck and Vioxx: Putting Patient Safety First?,' chairman Sen Charles Grassley (R-Iowa) and ranking member [...]

Published
2004

40. Merck's Mess

Author

Herper, Matt and Langreth, Robert

Subjects
Vioxx (Medication) -- Health aspects, Vioxx (Medication) -- Adverse and side effects, Vioxx (Medication) -- Cases, Pharmaceutical industry -- Management, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Beliefs, opinions and attitudes, Pharmaceutical industry -- Product information, Company legal issue, Company business management, Merck & Company Inc. -- Management, Merck & Company Inc. -- Cases, Merck & Company Inc. -- Beliefs, opinions and attitudes, Merck & Company Inc. -- Product information
Published
2004

41. Vioxx News a Shot in the Arm for Plaintiffs

Author

Scheck, Justin

Subjects
Merck & Company Inc. -- Product discontinuation, Merck & Company Inc. -- Cases, Pharmaceutical industry -- Product discontinuation, Pharmaceutical industry -- Cases, Personal injuries -- Cases, Antiarthritic agents -- Product discontinuation, Antiarthritic agents -- Complications and side effects, Antiarthritic agents -- Cases, Company legal issue, Business, regional, Law, Vioxx (Medication) -- Product discontinuation, Vioxx (Medication) -- Complications and side effects, Vioxx (Medication) -- Cases
Published
2004

42. Vioxx withdrawal shakes pharmaceutical industry

Author

Bond, Daniel

Subjects
Company legal issue, Merck & Company Inc. -- Cases, Vioxx (Medication) -- Health aspects, Vioxx (Medication) -- Cases, Analgesics -- Cases
Abstract

One of the most widely prescribed arthritis and acute pain medications in the world has been pulled from the market, causing long-term implications for both the maker and users of [...]

Published
2004

43. Merck To Settle Charges Vioxx Was Illegally Promoted

Subjects
Merck & Company Inc. -- Cases, False advertising -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, Vioxx (Medication) -- Cases
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=142693125 The pharmaceutical company Merck has agreed to pay nearly a billion dollars to settle charges that it illegally marketed its painkiller, Vioxx. [...]

Published
2011

44. Merck Ordered to Pay $4.5 Million in N.J. Vioxx Case

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, Vioxx (Medication) -- Cases
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=5327164 STEVE INSKEEP, host: Here's some more mixed news for the makers of Vioxx. A jury in New Jersey yesterday awarded four and [...]

Published
2006

45. Analysis: Jury favors Merck in Vioxx lawsuit

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, Vioxx (Medication) -- Cases
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=4987962 STEVE INSKEEP, host: The business news starts with a verdict supporting Vioxx. A jury in New Jersey ruled in favor of the [...]

Published
2005

46. Analysis: Widow awarded $250 million in Vioxx death suit

Subjects
Company legal issue, Vioxx (Medication) -- Cases
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=4807634 ROBERT SIEGEL, host: From NPR News, this is ALL THINGS CONSIDERED. I'm Robert Siegel. Jurors in Texas have awarded a quarter of [...]

Published
2005

47. Analysis: Jury hears final arguments in Vioxx case

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, Vioxx (Medication) -- Cases
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=4804921 STEVE INSKEEP, host: This is MORNING EDITION from NPR News. I'm Steve Inskeep. SUSAN STAMBERG, host: I'm Susan Stamberg. In Angleton, Texas, [...]

Published
2005

48. Analysis: Closing arguments to begin in Vioxx case

Subjects
Merck & Company Inc. -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, Vioxx (Medication) -- Cases
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=4801455 STEVE INSKEEP, host: This is MORNING EDITION from NPR News. I'm Steve Inskeep. In Angleton, Texas, jurors tomorrow will hear closing arguments [...]

Published
2005

49. Juries deliver differing Vioxx verdicts

Author

Schneider, Mary Ellen

Subjects
Merck & Company Inc. -- Cases, Products liability -- Cases, Pharmaceutical industry -- Cases, Company legal issue, Health, Health care industry, Vioxx (Medication) -- Cases
Abstract

The pharmaceutical industry may be breathing a collective sigh of relief over the latest court verdict involving Merck & Co.'s Vioxx, but it may not be time to pop the [...]

Published
2006

50. U.S. Supreme Court considers limitations issue in Vioxx case

Author

Atkins, Kimberly

Subjects
Products liability -- Laws, regulations and rules, Products liability -- Cases, Government regulation, Company legal issue, Law, News, opinion and commentary, Vioxx (Medication) -- Cases, Vioxx (Medication) -- Product defects and recalls
Abstract

The U.S. Supreme Court is set to decide when the statute of limitations began to run in a case brought by investors who claim a drug company made fraudulent claims [...]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results